PapersFlow Research Brief
Uterine Myomas and Treatments
Research Guide
What is Uterine Myomas and Treatments?
Uterine myomas, also known as uterine leiomyomas or fibroids, are benign tumors of the uterine smooth muscle, with treatments including hysterectomy, uterine artery embolization, MRI-guided interventions, and hormonal therapies such as progesterone modulation.
The field encompasses 67,577 papers on uterine leiomyomas, their epidemiology, and treatments like hysterectomy and uterine artery embolization. High cumulative incidence of uterine leiomyoma occurs in black and white women, as shown by ultrasound evidence in "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" (Baird et al., 2003). Studies address reproductive outcomes, health-related quality of life, and comparisons of surgical approaches including vaginal hysterectomy over laparoscopic and abdominal methods.
Topic Hierarchy
Research Sub-Topics
Uterine Leiomyoma Pathogenesis
This sub-topic investigates genetic mutations like MED12, hormonal influences, and molecular signaling pathways in fibroid development. Researchers study racial disparities and epigenetic factors.
Medical Management of Uterine Fibroids
Research evaluates GnRH agonists, selective progesterone receptor modulators, and novel ulipristal acetate therapies for symptom relief. It assesses fertility preservation and side effect profiles.
Uterine Artery Embolization
This area examines procedural techniques, symptom resolution rates, and long-term recurrence in minimally invasive embolization. Studies compare outcomes to myomectomy and hysterectomy.
Hysterectomy Techniques for Myomas
Comparative studies analyze laparoscopic, robotic, and abdominal approaches for fibroid removal, focusing on complications and recovery. Research addresses morcellation risks and oncologic safety.
Reproductive Outcomes After Fibroid Treatment
This sub-topic tracks fertility rates, pregnancy complications, and live birth success post-myomectomy or embolization. It stratifies risks by fibroid location and patient age.
Why It Matters
Uterine myomas affect reproductive-age women, leading to symptoms that necessitate treatments impacting fertility and quality of life. "Surgical approach to hysterectomy for benign gynaecological disease" (Aarts et al., 2015) found vaginal hysterectomy superior to laparoscopic and abdominal hysterectomy, with faster return to normal activities and fewer postoperative febrile episodes among women with benign disease. "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" (Baird et al., 2003) documented elevated incidence rates via ultrasound, informing epidemiological risk assessment. Hysterectomy variants, including minimally invasive approaches, influence disease-free survival, as in "Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer" (Ramírez et al., 2018), where open abdominal methods showed better outcomes than minimally invasive radical hysterectomy in early-stage cervical cancer cases involving uterine procedures.
Reading Guide
Where to Start
"High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" (Baird et al., 2003) provides essential epidemiological foundation via ultrasound data on incidence, ideal for initial understanding of prevalence.
Key Papers Explained
"High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" (Baird et al., 2003) establishes baseline epidemiology, which informs surgical choices in "Surgical approach to hysterectomy for benign gynaecological disease" (Aarts et al., 2015) favoring vaginal over laparoscopic and abdominal hysterectomy. This connects to oncologic contexts in "Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer" (Ramírez et al., 2018), contrasting minimally invasive with open methods for survival outcomes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus shifts to uterine artery embolization and MRI guidance for myomas, alongside progesterone action studies and reproductive outcomes, as no recent preprints or news specify new developments.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Endometriosis | 2004 | The Lancet | 3.0K | ✕ |
| 2 | Revised American Society for Reproductive Medicine classificat... | 1997 | Fertility and Sterility | 2.9K | ✕ |
| 3 | High cumulative incidence of uterine leiomyoma in black and wh... | 2003 | American Journal of Ob... | 2.4K | ✕ |
| 4 | ESHRE guideline: management of women with endometriosis | 2014 | Human Reproduction | 2.2K | ✓ |
| 5 | Endometriosis | 2020 | New England Journal of... | 1.9K | ✕ |
| 6 | Endometriosis | 2010 | New England Journal of... | 1.9K | ✕ |
| 7 | Endometriosis: pathogenesis and treatment | 2013 | Nature Reviews Endocri... | 1.8K | ✕ |
| 8 | The American Fertility Society classifications of adnexal adhe... | 1988 | Fertility and Sterility | 1.8K | ✕ |
| 9 | Surgical approach to hysterectomy for benign gynaecological di... | 2015 | Cochrane Database of S... | 1.8K | ✓ |
| 10 | Minimally Invasive versus Abdominal Radical Hysterectomy for C... | 2018 | New England Journal of... | 1.8K | ✓ |
Frequently Asked Questions
What is the cumulative incidence of uterine leiomyoma?
Ultrasound evidence reveals a high cumulative incidence of uterine leiomyoma in black and white women. "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" (Baird et al., 2003) provides data from prospective ultrasound screening. This incidence rises with age during reproductive years.
How does vaginal hysterectomy compare to other approaches for benign disease?
Vaginal hysterectomy is superior to laparoscopic and abdominal hysterectomy for benign gynaecological disease. "Surgical approach to hysterectomy for benign gynaecological disease" (Aarts et al., 2015) reports faster return to normal activities and fewer febrile episodes postoperatively with vaginal hysterectomy. It should be preferred when technically feasible over abdominal hysterectomy.
What are key treatments for uterine conditions like myomas?
Treatments include hysterectomy, uterine artery embolization, and MRI-guided procedures. The cluster covers reproductive outcomes after these interventions and progesterone's role. Hysterectomy approaches vary by minimally invasive versus open methods, affecting recovery and survival.
What is the current scale of research on uterine myomas?
Research comprises 67,577 papers on uterine leiomyomas and treatments. Topics include epidemiology, sarcomas, embolization, and quality of life impacts. Growth data over five years is not available.
How do hysterectomy methods impact survival in uterine-related cancers?
Minimally invasive radical hysterectomy links to lower disease-free and overall survival compared to open abdominal radical hysterectomy in early-stage cervical cancer. "Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer" (Ramírez et al., 2018) trial data supports this. Open approaches yield better outcomes.
Open Research Questions
- ? What factors drive the high cumulative incidence of uterine leiomyomas observed via ultrasound in diverse populations?
- ? How can uterine artery embolization improve reproductive outcomes compared to hysterectomy?
- ? What role does progesterone play in the pathogenesis and treatment of uterine myomas?
- ? Which MRI-guided techniques optimize treatment efficacy for uterine fibroids?
- ? How do health-related quality of life measures vary post-treatment for uterine sarcomas?
Recent Trends
The field maintains 67,577 papers with no specified five-year growth rate.
Emphasis persists on hysterectomy comparisons and leiomyoma epidemiology from top-cited works like Baird et al.
2003No recent preprints or news coverage indicate ongoing frontiers in embolization or MRI guidance.
Research Uterine Myomas and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Uterine Myomas and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers